175 results
S-8
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Registration of securities for employees
6:59am
that are incorporated by reference in this Registration Statement.
That, for the purpose of determining any liability under the Securities Act, each such post
S-8
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Registration of securities for employees
6:59am
approval obtained on May 1, 2024.
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h
424B3
KPRX
Kiora Pharmaceuticals Inc
28 Mar 24
Prospectus supplement
4:48pm
cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant … owners of these securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or any other purpose
8-K
EX-10.2
arbcbix
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-4.1
163wksfya1ok0
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-4.2
3o3sh6532q3kjp7v1yif
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-4.3
pr6n9e61ns0
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
93v wlgfakby
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
elvq52w i3
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
S-8
k35x67bt7 ox30
13 Oct 23
Registration of securities for employees
5:09pm
S-8
j4jyv0rkctoezvt
13 Oct 23
Registration of securities for employees
5:09pm